Related Experiment Videos

Homocysteine inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion via nuclear

V Stangl1, C Günther, A Jarrin

  • 1Medizinische Klinik und Poliklinik, Schwerpunkt Kardiologie, Angiologie and Pneumologie, Charité der Humboldt-Universität, Campus Mitte, Berlin, Germany. verena.stangl@charite.de

Insights

Homocysteine reduces the expression of key adhesion molecules like ICAM-1, VCAM-1, and E-selectin on endothelial cells. This finding suggests a potential therapeutic role for homocysteine in mitigating atherosclerosis development.

Area of Science:

  • Cardiovascular biology
  • Endothelial cell research
  • Atherosclerosis pathogenesis

Background:

  • Cellular adhesion molecules mediate leukocyte adherence, a key step in atherosclerosis.
  • Hyperhomocysteinemia is an independent risk factor for atherosclerosis development.

Purpose of the Study:

  • To investigate homocysteine's effect on endothelial adhesion molecule expression.
  • To determine if homocysteine influences TNF-alpha-induced adhesion molecule upregulation.

Main Methods:

  • Human umbilical vein endothelial cells were incubated with homocysteine.
  • Expression of ICAM-1, VCAM-1, and E-selectin was measured.
  • U-937 cell adhesion and NF-kappaB activation were assessed.

Main Results:

  • Homocysteine dose-dependently reduced TNF-alpha-induced VCAM-1, E-selectin, and ICAM-1 expression.
  • This effect was specific to homocysteine, not mimicked by cysteine or glutathione.
  • Homocysteine attenuated U-937 cell adhesion and reduced NF-kappaB activation.

Conclusions:

  • Homocysteine inhibits the expression of key endothelial adhesion molecules.
  • NF-kappaB inhibition is a likely mechanism underlying homocysteine's effect.
  • Homocysteine may play a role in preventing atherosclerosis progression.

Related Concept Videos